
Syed M. Kaiser
Examiner (ID: 2619, Phone: (571)272-9612 , Office: P/2844 )
| Most Active Art Unit | 2831 |
| Art Unit(s) | 2844, 2831 |
| Total Applications | 862 |
| Issued Applications | 727 |
| Pending Applications | 79 |
| Abandoned Applications | 90 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9413698
[patent_doc_number] => 08697734
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-15
[patent_title] => 'Method for controlling particular insect pests by applying anthranilamide compounds'
[patent_app_type] => utility
[patent_app_number] => 13/571852
[patent_app_country] => US
[patent_app_date] => 2012-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59725
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13571852
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/571852 | Method for controlling particular insect pests by applying anthranilamide compounds | Aug 9, 2012 | Issued |
Array
(
[id] => 10850567
[patent_doc_number] => 08877245
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-04
[patent_title] => 'Modified release dosage forms of skeletal muscle relaxants'
[patent_app_type] => utility
[patent_app_number] => 13/570670
[patent_app_country] => US
[patent_app_date] => 2012-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 5202
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13570670
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/570670 | Modified release dosage forms of skeletal muscle relaxants | Aug 8, 2012 | Issued |
Array
(
[id] => 9068161
[patent_doc_number] => 20130259916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-03
[patent_title] => 'BACTERICIDAL SILVER SURFACTANT DELIVERY INTO COATING AND POLYMER COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/571040
[patent_app_country] => US
[patent_app_date] => 2012-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21054
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13571040
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/571040 | Bactericidal silver surfactant delivery into coating and polymer compositions | Aug 8, 2012 | Issued |
Array
(
[id] => 9588855
[patent_doc_number] => 08778394
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-15
[patent_title] => 'Small-volume oral transmucosal dosage forms'
[patent_app_type] => utility
[patent_app_number] => 13/561543
[patent_app_country] => US
[patent_app_date] => 2012-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 21715
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13561543
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/561543 | Small-volume oral transmucosal dosage forms | Jul 29, 2012 | Issued |
Array
(
[id] => 9354801
[patent_doc_number] => 08673332
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-18
[patent_title] => 'Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens'
[patent_app_type] => utility
[patent_app_number] => 13/560538
[patent_app_country] => US
[patent_app_date] => 2012-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 6946
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13560538
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/560538 | Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens | Jul 26, 2012 | Issued |
Array
(
[id] => 8796701
[patent_doc_number] => 08435568
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-07
[patent_title] => 'Use of WF10 for treating allergic asthma, allergic rhinitis and atopic dermatitis'
[patent_app_type] => utility
[patent_app_number] => 13/560032
[patent_app_country] => US
[patent_app_date] => 2012-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5515
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13560032
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/560032 | Use of WF10 for treating allergic asthma, allergic rhinitis and atopic dermatitis | Jul 26, 2012 | Issued |
Array
(
[id] => 8884890
[patent_doc_number] => 20130158074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-20
[patent_title] => 'SMALL VOLUME ORAL TRANSMUCOSAL DOSAGE FORMS CONTAINING SUFENTANIL FOR TREATMENT OF PAIN'
[patent_app_type] => utility
[patent_app_number] => 13/555948
[patent_app_country] => US
[patent_app_date] => 2012-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 24167
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13555948
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/555948 | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain | Jul 22, 2012 | Issued |
Array
(
[id] => 8796694
[patent_doc_number] => 08435561
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-07
[patent_title] => 'Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/542164
[patent_app_country] => US
[patent_app_date] => 2012-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3711
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13542164
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/542164 | Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof | Jul 4, 2012 | Issued |
Array
(
[id] => 8796694
[patent_doc_number] => 08435561
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-07
[patent_title] => 'Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/542164
[patent_app_country] => US
[patent_app_date] => 2012-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3711
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13542164
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/542164 | Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof | Jul 4, 2012 | Issued |
Array
(
[id] => 8489160
[patent_doc_number] => 20120288567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-15
[patent_title] => 'Opioid Agonist Formulations with Releasable And Sequestered Antagonist'
[patent_app_type] => utility
[patent_app_number] => 13/535605
[patent_app_country] => US
[patent_app_date] => 2012-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23090
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13535605
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/535605 | Opioid agonist formulations with releasable and sequestered antagonist | Jun 27, 2012 | Issued |
Array
(
[id] => 8489160
[patent_doc_number] => 20120288567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-15
[patent_title] => 'Opioid Agonist Formulations with Releasable And Sequestered Antagonist'
[patent_app_type] => utility
[patent_app_number] => 13/535605
[patent_app_country] => US
[patent_app_date] => 2012-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23090
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13535605
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/535605 | Opioid agonist formulations with releasable and sequestered antagonist | Jun 27, 2012 | Issued |
Array
(
[id] => 10856984
[patent_doc_number] => 08883177
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-11
[patent_title] => 'Pharmaceutical compositions for parenteral administration'
[patent_app_type] => utility
[patent_app_number] => 13/532023
[patent_app_country] => US
[patent_app_date] => 2012-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5413
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13532023
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/532023 | Pharmaceutical compositions for parenteral administration | Jun 24, 2012 | Issued |
Array
(
[id] => 8429600
[patent_doc_number] => 20120251475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => 'WATER SOLUBLE POLYMER COMPLEXES WITH SURFACTANTS'
[patent_app_type] => utility
[patent_app_number] => 13/493092
[patent_app_country] => US
[patent_app_date] => 2012-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11408
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13493092
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/493092 | Water soluble polymer complexes with surfactants | Jun 10, 2012 | Issued |
Array
(
[id] => 9588844
[patent_doc_number] => 08778383
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-15
[patent_title] => 'Methods of treatment'
[patent_app_type] => utility
[patent_app_number] => 13/491275
[patent_app_country] => US
[patent_app_date] => 2012-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 58
[patent_no_of_words] => 30381
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13491275
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/491275 | Methods of treatment | Jun 6, 2012 | Issued |
Array
(
[id] => 8834157
[patent_doc_number] => 08449912
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-28
[patent_title] => 'Sustained release compositions of alfuzosin'
[patent_app_type] => utility
[patent_app_number] => 13/475968
[patent_app_country] => US
[patent_app_date] => 2012-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5518
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13475968
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/475968 | Sustained release compositions of alfuzosin | May 18, 2012 | Issued |
Array
(
[id] => 8393210
[patent_doc_number] => 20120231045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-13
[patent_title] => 'SUSTAINED RELEASE COMPOSITIONS OF ALFUZOSIN'
[patent_app_type] => utility
[patent_app_number] => 13/475983
[patent_app_country] => US
[patent_app_date] => 2012-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5512
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13475983
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/475983 | Sustained release compositions of alfuzosin | May 18, 2012 | Issued |
Array
(
[id] => 8381498
[patent_doc_number] => 20120225124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-06
[patent_title] => 'STABLE LAQUINIMOD PREPARATIONS'
[patent_app_type] => utility
[patent_app_number] => 13/471175
[patent_app_country] => US
[patent_app_date] => 2012-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5224
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13471175
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/471175 | Stable laquinimod preparations | May 13, 2012 | Issued |
Array
(
[id] => 9454709
[patent_doc_number] => 08715713
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-06
[patent_title] => 'Solvent cast film sustained release latanoprost implant'
[patent_app_type] => utility
[patent_app_number] => 13/457785
[patent_app_country] => US
[patent_app_date] => 2012-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4450
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13457785
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/457785 | Solvent cast film sustained release latanoprost implant | Apr 26, 2012 | Issued |
Array
(
[id] => 9093848
[patent_doc_number] => 20130273159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-17
[patent_title] => 'Immediate release compositions and methods for delivering drug formulations using weak acid ion exchange resins in abnormally high pH environments'
[patent_app_type] => utility
[patent_app_number] => 13/506512
[patent_app_country] => US
[patent_app_date] => 2012-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6450
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13506512
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/506512 | Immediate release compositions and methods for delivering drug formulations using weak acid ion exchange resins in abnormally high pH environments | Apr 22, 2012 | Issued |
Array
(
[id] => 8642130
[patent_doc_number] => 08367110
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-05
[patent_title] => 'Polymeric drug delivery compositions and methods for treating ophthalmic diseases'
[patent_app_type] => utility
[patent_app_number] => 13/439969
[patent_app_country] => US
[patent_app_date] => 2012-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7938
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13439969
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/439969 | Polymeric drug delivery compositions and methods for treating ophthalmic diseases | Apr 4, 2012 | Issued |